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ADP Protects Cardiac Mitochondria under Severe
Oxidative Stress
Niina Sokolova1, Shi Pan3, Sarah Provazza2, Gisela Beutner2, Marko Vendelin1, Rikke Birkedal1*, SheyShing Sheu2,3*
1 Institute of Cybernetics, Tallinn University of Technology, Tallinn, Estonia, 2 Department of Pharmacology and Physiology, University of Rochester, Rochester,
New York, United States of America, 3 Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

Abstract
ADP is not only a key substrate for ATP generation, but also a potent inhibitor of mitochondrial permeability transition
pore (mPTP). In this study, we assessed how oxidative stress affects the potency of ADP as an mPTP inhibitor and
whether its reduction of reactive oxygen species (ROS) production might be involved. We determined quantitatively
the effects of ADP on mitochondrial Ca2+ retention capacity (CRC) until the induction of mPTP in normal and stressed
isolated cardiac mitochondria. We used two models of chronic oxidative stress (old and diabetic mice) and two
models of acute oxidative stress (ischemia reperfusion (IR) and tert-butyl hydroperoxide (t-BH)). In control
mitochondria, the CRC was 344 ± 32 nmol/mg protein. 500 μmol/L ADP increased CRC to 774 ± 65 nmol/mg protein.
This effect of ADP seemed to relate to its concentration as 50 μmol/L had a significantly smaller effect. Also,
oligomycin, which inhibits the conversion of ADP to ATP by F0F1ATPase, significantly increased the effect of 50
μmol/L ADP. Chronic oxidative stress did not affect CRC or the effect of 500 μmol/L ADP. After IR or t-BH exposure,
CRC was drastically reduced to 1 ± 0.2 and 32 ± 4 nmol/mg protein, respectively. Surprisingly, ADP increased the
CRC to 447 ± 105 and 514 ± 103 nmol/mg protein in IR and t-BH, respectively. Thus, it increased CRC by the same
amount as in control. In control mitochondria, ADP decreased both substrate and Ca2+-induced increase of ROS.
However, in t-BH mitochondria the effect of ADP on ROS was relatively small. We conclude that ADP potently
restores CRC capacity in severely stressed mitochondria. This effect is most likely not related to a reduction in ROS
production. As the effect of ADP relates to its concentration, increased ADP as occurs in the pathophysiological
situation may protect mitochondrial integrity and function.
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Introduction

Ca2+ and ADP are also major modulators of mPTP [4–7]. But
here, they function oppositely. Physiologically, the mPTP may
open briefly, functioning as a mitochondrial Ca2+-release
channel [8]. Pathologically, mitochondrial Ca2+-overload
triggers irreversible opening of mPTP, which is a major cause
of cell death. ADP, on the contrary, is a potent inhibitor of
mPTP [6,7].
The molecular identity of mPTP is still unsolved. Two
hypotheses exist regarding the pore-forming component. Both
involve cyclophilin D (CypD) and ADP as regulators. CypD is a
peptidyl-prolyl cis-trans isomerase, which binds to several
proteins including ANT, the mitochondrial phosphate carrier
(mPiC) and F1F0 ATPase, and increases mPTP Ca2+-sensitivity
[9]. Irrespective of its exact site of action, it was shown that
cyclosporine A (CsA) binding to CypD inhibits mPTP opening

Ca2+ and ADP are the two major regulators of mitochondrial
energy metabolism that function in coordination to keep the
balance between the energy demand and supply. In cardiac
muscle cells, during the excitation-contraction coupling, Ca2+
enters mitochondria to stimulate Krebs’ cycle. As such, the
nicotinamide adenine dinucleotide redox potential and ATP
synthesis required for cardiac workload are maintained [1].
Concomitantly, ADP generated by ATPases and kinases enters
the mitochondrial matrix via the adenine nucleotide translocase
(ANT) and stimulates ATP-production by F1F0-ATPase [2,3].
Therefore, both Ca2+ and ADP have a positive impact on ATP
generation under physiological conditions.
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by unmasking an inhibitory Pi-binding site [10]. Some suggest
that mPiC is the pore-forming component and mainly regulated
by CypD and ANT [11]. ANT in the “c” (cytosol) or “m” (matrix)
conformation increases or decreases mPTP Ca2+-sensitivity,
respectively. ADP decreases Ca2+-sensitivity, because its
binding shifts ANT to the “m” conformation [12]. Others suggest
that dimers of F1F0-ATPase are responsible for the formation of
mPTP [13]. CypD also binds and inhibits F1F0-ATPase activity
[14], and ADP is a potent inhibitor of the channel activity of
F0F1-ATPase dimers [13].
Until today, little is known about the effect of ADP on mPTP
in diseased mitochondria, which experience increased
oxidative stress, Ca2+-load, and energy deficiency. ADP-binding
to ANT is reduced by oxidative stress [15], which might reduce
the inhibiting effect of ADP on mPTP. In this paper, we wanted
to address the potency of ADP as an mPTP inhibitor in
diseased mitochondria with the hope to obtain clues about its
mechanism of action. As noted above, ADP may exert its
function by binding to either ANT or the F0F1-ATPase. But ADP
may also enhance Ca2+-sequestration in the form of Ca2+phosphate precipitates [16,17]. Furthermore, it may be
speculated that part of the ADP-effect on Ca2+-uptake capacity
is due to its reduction of ROS production [18]. Indeed, as the
substrate of F1F0-ATPase, which uses the electrochemical
energy stored in the proton gradient to produce ATP, ADP
should reduce ROS production.
In this study, we assessed at the level of isolated
mitochondria from mouse hearts how chronic and acute
oxidative stress affects the effect of ADP on CRC and ROS
production. As models of long-term oxidative stress, we used
old mice and diabetic mice. As models of acute oxidative
stress, we used IR and exposure to a low dose of t-BH.

Henseleit buffer as in [19]. After 10 min of equilibration, hearts
were subjected to 15 min of global ischemia followed by 60 min
of reperfusion.
Unless otherwise stated, the mice were euthanized by CO2
inhalation and sacrificed by cervical dislocation.

Isolation of heart mitochondria
Mitochondria from 2-4 mouse hearts were isolated using the
protocol of Rehncrona et al with modifications [20]. The minced
heart tissue was subjected to protease treatment: it was
incubated with 5 mg nagarse dissolved in 10 ml medium A for 8
minutes at room temperature while gently stirring. The protease
reaction was stopped by adding 1 ml of 0.2 mg/ml of bovine
serum albumin dissolved in medium A. The tissue was then
homogenized with a Potter-Elvehjem homogenizer, and
mitochondria were isolated by differential centrifugation. The
final mitochondrial pellet was suspended in isolation medium B.
For mitochondrial ROS generation measurements,
mitochondria were Ca2+ depleted to minimize possible
signalling of Ca2+ on ROS generation [21]. This procedure
consisted of 15 min incubation at room temperature in Ca2+depletion buffer. The mitochondria were subsequently washed
several times in a Ca2+-depletion buffer without NaCl, EGTA
and succinate. The isolated mitochondria were kept on ice and
used within 4 hours. Protein concentration was determined by
the Lowry method using BSA as a standard.

Ca2+ uptake measurements with arsenazo III
Ca2+ uptake was measured with arsenazo III at room
temperature as a difference in absorbance at 662 nm and the
background at 692 nm using Beckman Coulter DU 800 UV-Vis
spectrophotometer (Beckman Coulter Inc., Brae, CA). Isolated
mitochondria (~1 mg/ml of mitochondrial protein) were added to
1 ml Ca2+-uptake buffer. The absorbance change upon Ca2+
addition was determined every 15 sec and followed for 30-70
min. Varying amounts of free Ca2+ were added every 2
minutes. Free Ca2+ concentrations were calculated using the
MaxChelator
program
(http://www.stanford.edu/~cpatton/
maxc.html).

Methods
Ethics Statement
All procedures were in accordance with the NIH Guide for
the Care and Use of Laboratory Animals and were approved by
an Institutional Animal Care and Use Committee (University
Committee on Animal Resources (UCAR) protocol 2010–030).

Animals and models of disease and oxidative stress
Measurement of mitochondrial ROS production

Control mice: 6-8 weeks old male C57BL6 mice (n=64).
Aging: 12-15-month old male C57BL6 mice (n=8). Diabetes: To
induce type I diabetes, 5 weeks old male C57BL6 mice (n=12)
were injected intraperitoneally with 150 mg/kg streptozotocin
dissolved in 0.1 mol/L sodium citrate buffer, pH 4, prepared
within 5 min of administration. Mice were given drinking water
supplemented with 7.5 % sucrose for 2.5 days to avoid severe
hyperglycemia. After 5 weeks the mice were diabetic and used
for experiments. Exposure to t-BH: Mitochondria from 6-8
weeks old C57BL6 male mice (n=44) were exposed to 5
µmol/L t-BH for 10 min before recording Ca2+-uptake or ROS
production. Ischemia-reperfusion injury: Male C57BL6 mice,
6-8 weeks old (n=20) were anesthetized with freshly prepared
Avertin
(2,2,2-tribromoethanol,
0.5
mg/kg
injected
intraperitoneally). Isolated hearts were retrogradely perfused in
Langendorff mode under constant flow (4 ml/min) with Krebs–
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Mitochondrial superoxide production was determined
indirectly by coupling the dismutation of superoxide to H2O2.
H2O2 was detected fluorimetrically using Amplex red (10acetyl-3,7-dihydroxyphenoxazine), which reacts with H2O2 in a
1:1 stochiometry in the presence of horseradish peroxidase
(HRP), producing highly fluorescent resorufin. For these
experiments, mitochondria (~0.5 mg/ml of mitochondrial
protein) were added to 2 ml ROS buffer. Fluorescence was
recorded at room temperature using a Cary Eclipse
fluorescence spectrophotometer (Varian Inc., Walnut Creek,
CA). The excitation wavelength was 563 nm and the emitted
fluorescence was detected at 587 nm. A calibration signal was
generated with known amounts of H2O2 at the end of each
experiment.
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Measurement of mitochondrial oxygen consumption

Table 1. Respiration of isolated mouse heart mitochondria
from control mice and different models of chronic and acute
oxidative stress.

Mitochondrial oxygen consumption was measured at room
temperature using a Clark-type oxygen electrode from
Hansatech (PP Systems, Boston MA).The measurements were
carried out in 1 ml of respiration medium. The basal rate of
respiration (State 2) was initiated by the addition of 5 mmol/L
glutamate and 5 mmol/L malate as substrates. Maximal
respiration rate (State 3) was measured in the presence of 1
mmol/L ADP. Respiration rates were expressed as nmol O2
min-1 mg mitochondrial protein-1. The respiratory control index
(RCI) was calculated as RCI = State3/State2. At the end of
each experiment, 8 μmol/L cytochrome c and 30 μmol/L
atractyloside were added to test the intactness of the outer and
inner mitochondrial membrane, respectively.

n

State 2

State 3

RCI

Control

10

13.1 ± 1.4

100.8 ± 12.0

7.6 ± 0.2

Aging

7

8.6 ± 0.8

61.3 ± 6.7*

7.0 ± 0.4

Diabetes

3

14.1 ± 2.8

83.8 ± 11.3

6.2 ± 0.9

IR

4

9.3 ± 1.1

48.8 ± 6.4

5.3 ± 0.6**

t-BH

3

9.3 ± 1.4

64.1 ± 8.6

6.9 ± 0.4

Basal respiration rate in the absence of ADP (State 2), respiration rate in the
presence of 1mmol/L ADP (State 3), and respiration control index (RCI = State 3/
State 2). Respiration rates are expressed as nmol O2 min-1 mg mitochondrial
protein-1. Number of experiments is given in column n. Results were compared by

Solutions

a nonparametric Mann–Whitney U test. * and ** denote P < 0.05 and P < 0.01,

Krebs–Henseleit buffer for Langendorff perfusion and IR (in
mmol/L): 118 NaCl, 4.7 KCl, 1.2 MgSO4 , 24 NaHCO3 , 1.2
KH2PO4, 2.5 CaCl2 , 11 D-glucose.
For isolation of mitochondria, medium A contained (in
mmol/L): 225 mannitol, 70 sucrose, 1 EGTA and 10 HEPES,
pH 7.2. Medium B contained (in mmol/L): 225 mannitol, 70
sucrose, and 10 HEPES, pH 7.2.
Ca2+-depletion buffer contained (in mmol/L): 195 mannitol,
25 sucrose, 40 HEPES, 10 NaCl, 1 EGTA, 5 succinate, pH 7.2
For recording mitochondrial CRC, the Ca2+-uptake buffer
contained (in mmol/L): 120 KCl, 70 mannitol, 25 sucrose, 5
KH2PO4, 0.5 EGTA, 10 HEPES, pH 7.2 in the presence of 5
mmol/L malate and 5 mmol/L glutamate as substrates and 100
μmol/L arsenazo III.
For recording ROS production, the ROS buffer contained (in
mmol/L): 120 KCl, 70 mannitol, 25 sucrose, 5 KH2PO4, 0.5
EGTA, 10 HEPES, pH 7.2, 10 μmol/L Amplex® red, 1 U/ml
type II HRP, and 80 U/ml Cu/Zn superoxide dismutase.
For respiration experiments, respiration medium contained
(in mmol/L): 120 KCl, 70 mannitol, 25 sucrose, 5 KH2PO4, 3
MgCl2, 0.5 EGTA, 20 HEPES, pH 7.2.

respectively, compared to control.
doi: 10.1371/journal.pone.0083214.t001

The low concentration of t-BH (5 µmol/L for 10 min) does not
affect glutamate and malate-dependent respiration [22], and
this was confirmed in our recordings, where State 2 and 3 and
RCI was not significantly different from control. RCI was
significantly lower after IR (5.3 ± 0.6, P = 0.009, n=4),
consistent with an inhibition of electron transport chain
activities after severe stress.

The protective effect of ADP is specific to [ADP]
The inhibition of mPTP by ADP has been widely reported
including the seminal studies by Haworth and Hunter [23–25],
in which the mPTP phenomenon was discovered. When adding
ADP to the solution with isolated mitochondria in the presence
of substrates, the majority will be converted into ATP. After a
short period of time, an equilibrium between [ADP] and [ATP]
will be reached. Oligomycin inhibits the conversion of ADP into
ATP by F1F0-ATPase. Thus, [ADP] will be higher in the
presence of oligomycin. We addressed the question whether
the total amount of adenine nucleotides ([ADP] + [ATP]) or
[ADP] specifically is important for the inhibition of mPTP.
Figures 1A and B show representative traces of Ca2+-uptake
recordings. Figure 1C summarizes the mitochondrial Ca2+uptake capacity under various conditions as indicated below
each column. Ca2+-uptake capacity for control and 500 μmol/L
ADP was 344 ± 32 nmol/mg protein and 774 ± 65 nmol/mg
protein, respectively, confirming that ADP inhibited mPTP
potently. 1 mmol/L ATP and 10 mmol/L creatine, which
stimulate mitochondrial creatine kinase to generate ADP, had a
similar effect as 500 μmol/L ADP on Ca2+-uptake capacity (P =
0.432). A smaller dose of ADP, 50 μmol/L, had a significantly
smaller effect increasing CRC to only 458 ± 30 nmol/mg protein
(Figure 1C) (P = 0.003 compared to 500 μmol/L ADP; P =
0.013 compared to 1 mmol/L ATP and creatine). Inhibition of
the F1F0-ATPase with 5 μmol/L oligomycin had a negative
effect on Ca2+-uptake capacity, which decreased to
approximately 62% of control (P = 0.016, Figure 1C). However,
in the presence of oligomycin, 50 µmol/L ADP had a
significantly larger effect on CRC, which increased from 213 ±

Statistical analysis
All values are expressed as mean ± SEM. Data were
analysed by a nonparametric Mann–Whitney U test.
Differences were considered significant at P < 0.05.

Results
RCI of mitochondrial preparations
The quality of the mitochondrial preparations was controlled
by recording their respiration rate in the presence of substrates
alone, State 2, and after addition of 1 mmol/L ADP, State 3.
RCI was calculated as State 3/State 2. These values are
shown in Table 1. RCI in control mice was 7.6 ± 0.2, n=10. The
respiratory parameters were not different in diabetic mice. Old
mice had a lower State 2 (8.6 ± 0.8, P = 0.057, n=7) and State
3 (61.3 ± 6.7, P = 0.028, n=7), but RCI was the same as in
control (7.0 ± 0.4, P = 0.222, n=7). This may be attributed to a
fraction of the mitochondria having already undergone mPTP.
However, their CRC was the same as in control (see below).

PLOS ONE | www.plosone.org
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Figure 1. Ca2+-uptake capacity of isolated heart mitochondria from control mice. A-B. Representative raw traces of the Ca2+uptake experiments. Mitochondria were incubated with Arsenazo III to follow extramitochondrial Ca2+ spectrophotometrically.
Consecutive pulses leading to an increase of 40 μmol/L free Ca2+ were added as indicated by arrow heads. The CRC was defined
as the concentration at which the mitochondria failed to accumulate more Ca2+ and mPTP opened to release all Ca2+ so far
accumulated by the mitochondria. A. Traces are shown with mitochondria from control mice, 6-8 weeks old, under control conditions
(no additions; black), in the presence of 500 µmol/L ADP (blue), 1 mmol/L ATP and 10 mmol/L creatine (Cr) (red), and 0.2 µmol/L
cyclosporine A (CsA) (turquoise). B. Representative raw traces of the Ca2+-uptake experiments in the presence of 5 µmol/L
oligomycin (green), 50 µmol/L ADP (orange), 5 µmol/L oligomycin and 50 µmol/L ADP (violet). C. Column diagrams of the averaged
results under the conditions indicated below. The amount of Ca2+ was normalized to the mitochondrial content (mg protein). All
values are mean ± SEM. * and ** denote significant difference P < 0.05, and P<0.01, respectively, between treatment and control.
The number of experiments is indicated below.
doi: 10.1371/journal.pone.0083214.g001

17 nmol/mg protein to 536 ± 49 nmol/mg protein. Thus, [ADP]
is the most important inhibitor of mPTP.
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ADP recovers mitochondrial Ca2+-uptake capacity after
acute oxidative stress

ADP attenuates ROS generation in control, but not after
exposure to t-BH

Figure 2 shows the CRC in the different models of oxidative
stress. Ca2+ was added consecutively to isolated mitochondria
until they reached their maximum uptake capacity, where
mPTP opened to release all Ca2+, causing an increase in
extramitochondrial Ca2+ as monitored by Arsenazo III
absorbance. Control mitochondria were able to sequester up to
10 pulses of 40 µmol/L free Ca2+ with a mean value of 344 ± 32
nmol/mg protein (Figure 1A and Figure 1C). We were surprised
to find that chronic oxidative stress did not affect the initial CRC
or the effect of ADP (Figure 2C-D). In contrast, acute oxidative
stress had an adverse effect on mitochondrial CRC by
facilitating mPTP opening. After IR or t-BH exposure, the first
addition of 40 µmol/L Ca2+ was able to trigger mPTP opening
(Figure 2B, red trace). Therefore, 0.2 µmol/L and 5 µmol/L Ca2+
additions were used for assessing mitochondrial CRC after IR
and t-BH treatments, respectively (Figure 2B). The CRC was
dramatically decreased to 1 ± 0.2 nmol/mg protein (IR) and 32
± 4 nmol/mg protein (t-BH) (Figure 2E-F).
CsA is a well-known inhibitor of CypD and protects against
ischemia-reperfusion damage at a concentration of 0.2 µmol/L
[26]. Indeed, this concentration of CsA increased CRC in all
models (Figure 2). 500 μmol/L ADP had a similar effect and
restored CRC to 447 ± 105 nmol/mg protein after IR and to 514
± 103 nmol/mg protein after t-BH exposure, respectively
(Figure 2E-F). The recovered CRC was not significantly
different from that of control mice in the absence of ADP (P =
0.109 for t-BH and P = 0.689 for IR, respectively, Figure 2E-F).
Thus, ADP is a potent inhibitor of mPTP – also in mitochondria,
which have been exposed to severe oxidative stress.

In addition to Ca2+, ROS are also potent activators of mPTP.
To determine whether ADP-mediated ROS decrease
contributes to the inhibition of mPTP, we measured ROS
production in the preparations. Amplex Red was used to record
ROS production with three consecutive steps: 1) mitochondria
alone, 2) after addition of substrates (glutamate and malate),
and 3) after the addition of one pulse of a submaximal Ca2+concentration to trigger partial opening of mPTP. The data on
ROS production in old and diabetic mice and after IR did not
give any new information. Therefore, we show only the results
from control and after t-BH exposure. Figure 4A shows original
traces of recordings from control mice and the results are
summarized in Figure 4C. As expected, ROS production
increased upon addition of substrates, as indicated by the
increase in the slope of Amplex Red fluorescence trace.
Addition of 250 μmol/L Ca2+ increased ROS production further
(Figure 4A and C, control). ADP or ATP and creatine, which
stimulate F1F0-ATPase to utilize the proton gradient, both
significantly abolished the substrate- and Ca2+-induced
increase in ROS generation (Figure 4C). CsA abolished mostly
the Ca2+-induced increase in ROS generation, but the net
effects were significantly smaller than those of ADP (Figure 4C,
P = 0.003 and P = 0.002 for substrate- and Ca2+-induced
increase in ROS generation, respectively).
In mitochondria exposed to t-BH, ROS-production was much
higher than in control (Figure 4B and D). Neither Ca2+ nor ADP
and CsA had a profound effect on ROS-production. This
implies that the ADP-induced increase in mitochondrial Ca2+uptake capacity is not related to a decrease in ROS-production
in mitochondria treated with t-BH.

Discussion

Similar effect of ADP irrespective of initial Ca2+-uptake
capacity

The most notable results from this study are that 1) ADP
increases CRC after IR and t-BH exposure to an extent that is
remarkably similar to that in control, and 2) the effect of ADP
on CRC in mitochondria exposed to t-BH is not the result of a
decreased ROS-production.

Figure 3 is a column diagram showing the effect of ADP –
i.e. how much does ADP increase CRC. It illustrates, as noted
above, that 50 µmol/L ADP increased CRC much more, when
F1F0-ATPase was inhibited by oligomycin (P = 0.008). But what
is in our opinion more remarkable, is the fact that although
CRC was drastically lowered by acute oxidative stress (IR and
t-BH) to the extent that mitochondrial Ca2+-buffering was almost
absent (Figure 2E-F), ADP exerted a similar effect as in
mitochondria from control mice. In control as well as all model
of oxidative stress, 500 µmol/L ADP increased CRC by
360-460 nmol/mg protein (Figure 3).
In mitochondria from control mice, the increase in Ca2+uptake capacity induced by 50 µmol/L ADP in the absence and
presence of oligomycin, and 500 µmol/L ADP alone and in the
presence of cyclosporine A (CsA) are shown as indicated. In
models of chronic and acute oxidative stress, the increase
induced by 500 µmol/L ADP is shown as indicated below the
columns. The increase induced by 500 µmol/L ADP is
remarkably consistent in control and the different models of
oxidative stress.

PLOS ONE | www.plosone.org

Inhibition of mPTP relates to the concentration of ADP
The main mechanism through which ADP decreases
mitochondrial Ca2+-sensitivity has been attributed to the binding
of ADP to ANT, which stabilizes the transporter in the m-state
and prevents pore opening [27]. It was demonstrated that ANT
is not a pore-forming component of the mPTP, as mPTP
opening is still triggered in mice lacking ANT1 and ANT2 [28].
However, the regulating role of ANT cannot be disputed, as
inhibition of ANT in different conformations by bongkrekic acid
or atractyloside has opposite effects on mitochondrial Ca2+sensitivity [4]. Haworth and Hunter proposed that ADP exerts
its effect by binding to an internal site as well as to ANT [23].
Recent studies suggest that either the mitochondrial phosphate
carrier or F1F0-ATPase could be one of the key components for
mPTP [13,14,29,30]. Both cases include a role for ADP [13,29].
In the latter case, ADP affects mPTP via direct binding to F0F1-
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Figure 2. Ca2+-uptake capacity of isolated mouse heart mitochondria from different models of chronic and acute oxidative
stress. A-B: Representative raw traces of the Ca2+-uptake from different models under control conditions. A. Control mice (black);
Aging (orange); Diabetes (violet). Pulses of 40 μmol/L free Ca2+ were added as indicated by arrow heads. B. Ischemia-reperfusion,
IR (green); exposure to 5 μmol/L tert-butyl hydroperoxide, t-BH, (blue). Pulses of 40 μmol/L (red), 0.2 μmol/L (green), and 5 μmol/L
(blue) free Ca2+ were added respectively as indicated by arrow heads. C-F: Column diagrams of the averaged results under the
conditions indicated below. The final concentrations of ADP and CsA are 500 μmol/L and 0.2 μmol/L, respectively. The amount of
Ca2+ was normalized to the mitochondrial content (mg protein). All values are mean ± SEM. * and ** denote significant difference P
< 0.05 and P < 0.01 respectively, between treatment and control within an animal group. # and ## denote significant difference P <
0.05 and P<0.01, respectively, between animal groups with similar treatment.
doi: 10.1371/journal.pone.0083214.g002
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Figure 3. Increase in mitochondrial Ca2+-uptake capacity induced by ADP.
doi: 10.1371/journal.pone.0083214.g003

However, the role of Ca2+-sequestration should be studied
further by quantifying intra- and extramitochondrial total and
free [Ca2+] as mitochondria take up Ca2+ after successive Ca2+pulses.

ATPase. This, however, does not exclude an additional effect
via ADP-binding to ANT.
The present study showed that the effect of ADP on CRC
relates to its concentration. 500 μmol/L ADP had a signifcantly
larger effect than 50 μmol/L ADP (Figure 1). Also, 50 μmol/L
ADP had a significantly larger effect in the presence of
oligomycin to inhibit ADP-turnover by F1F0-ATPase (Figure 1BC). Thus, the effect of ADP is specific to [ADP] and not the total
concentration of adenine nucleotides.
It is noticed that oligomycin on its own has a negative effect
on mitochondrial Ca2+-uptake capacity (Figure 1B-C). The
mitochondrial membrane potential decreases as the
mitochondria take up a significant amout of Ca2+. It is
conceivable that in the absence of oligomycin, the mitochondria
will hydrolyze ATP to ADP in order to maintain their membrane
potential. However, oligomycin renders the mitochondria
unable to rescue their membrane potential, so that the critical
potential at which mPTP opens is reached at a lower Ca2+concentration.

Similar effect of ADP on CRC in all models of oxidative
stress
Oxidative stress has an unfavourable effect on mitochondrial
CRC [5]. We studied the effect of ADP on CRC in different
models of increased oxidative stress. Chronic oxidative stress
by aging and diabetes had no significant impact on CRC or the
effect of ADP. However, the acute oxidative damage caused by
IR and t-BH drastically lowered CRC to the extent that
mitochondrial Ca2+-uptake was almost absent. It is interesting
that ADP was able to restore this function (Figures 2E-F) and
with an effect that was similar to that in control (Figure 3). It
appears that irrespective of the healthiness of mitochondria, a
certain amount of ADP increases CRC by a certain amount.
This is interesting, because ADP-binding to ANT is reduced by
oxidative stress [15]. Therefore, our results suggest that
although ADP to some extent inhibits mPTP opening via
binding to ANT, significant inhibition also occurs by some other
mechanism.

Ca2+-sequestration has no significant effect on CRC
ADP can buffer Ca2+ by itself [31], and could have an
additional effect on mitochondrial Ca2+ buffering such as the
maintenance of high matrix Pi concentrations. It has been
shown that ATP-Mg2-/Pi2- and HADP2-/Pi2- can increase matrix
Ca2+ buffering via Ca2+-Pi precipitates and thus desensitize the
mPTP [32,33]. Mitochondrial Ca2+-sequestration is proportional
to the ADP-uptake [32]. If Ca2+-sequestration played a
significant role in the effect of ADP, we would expect that the
Ca2+-uptake capacity is increased more by 500 µmol/L ADP
than by 50 µmol/L ADP in the presence of oligomycin. Our
results suggest that this is not the case (Figures 1 and 3).
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ADP does not increase CRC via an effect on ROSproduction in mitochondria exposed to t-BH
In addition to Ca2+, ROS also effectively trigger mPTP
openings. One of the aims of this study was to see whether
ADP might affect mitochondrial CRC via ROS decrease in the
models of oxidative stress. In our study, we used Amplex red
and horseradish peroxidase as a H2O2 detection system. This
allowed us to use the efflux of H2O2 from mitochondria as a
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Figure 4. Rate of ROS production in mitochondria from control mice and after t-BH exposure. A-B: Representative raw
traces of the ROS-recordings. The rate of hydrogen peroxide (H2O2) production was followed spectrofluorometrically by its reaction
with Amplex Red in the presence of horseradish peroxidase. The rate of ROS production was recorded in three consecutive steps:
After addition of mitochondria alone, after addition of substrates (5 mM glutamate and 5 mM malate) and after addition of one
submaximal dose of Ca2+. Traces are shown under control conditions (no additions; black), in the presence of 500 µmol/L ADP
(blue), 0.2 µmol/L CsA (green), and 1mmol/L ATP + 10 mmol/L creatine (Cr) (red). A: control mice; B: after exposure to 5 μmol/L tBH. C-D: Column diagrams of the averaged results under the conditions indicated below each column. Steady-state H2O2
production was recorded in the mitochondria alone (rate between 1-3 min; white columns), after addition of substrates (rate between
6.5-8.5 min; light grey columns), and after addition Ca 2+ (rate between 11-15 min; dark grey columns). Treatments within each group
are indicated below the columns. All values are mean ± SEM. † and †† denote significant effect of substrates and/or Ca2+, P < 0.05,
P < 0.01 respectively. *, ** denote significant difference P < 0.05, and P < 0.01, respectively, between control and different
treatments within the group. #and ## denote significant difference (P < 0.05 and P<0.01, respectively) between control and t-BH with
the same treatment. The number of experiments is indicated below.
doi: 10.1371/journal.pone.0083214.g004
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more Ca2+, before opening of mPTP is triggered. In the present
study, we found that ADP had the same effect in severely
stressed mitochondria as in control. This suggests that ADP, in
addition to its regulation via ANT, exerts significant regulation
of mPTP via some other mechanism. Although ADP decreases
ROS production in control mitochondria, its effect is minor in tBH-treated mitochondria. Therefore, we conclude that at least
in some cases e.g. t-BH treatment, the ADP-induced increase
in mitochondrial Ca2+-uptake capacity is not related to a
reduction in ROS. It is likely that significant regulation by ADP
occurs via its internal binding site (reported in [23]), which
could be on F1F0-ATPase [29].
From a more integrated point of view, it is very interesting
that ADP is as potent an inhibitor of mPTP in severely
stresssed mitochondria, and that its effect relates to the
concentration. Namely, ADP concentrations increase in the
diseased state due to less efficienct ATP production,
depolarized mitochondrial membrane potential, Ca2+ overload,
and a smaller pH gradient [47–49]. It is plausible that this
increase in ADP concentration could protect against opening of
mPTP and thus delay the injury and death of cells. This
function of ADP as a regulator of mitochondrial ATP
production, Ca2+ homeostasis, and ROS generation is shown
schematically in Figure 5. Under physiological conditions, it
serves as a substrate for ATP synthesis while ensuring the
closure of mPTP and modest ROS generation. Under
pathological conditions like IR injury, when the mitochondria
are most vulnerable for mPTP opening, ADP can effectively
delay mPTP opening so that mitochondrial membrane integrity
can be preserved to maintain energy production. The ability of
ADP to serve multiple roles as a potent mPTP blocker, a
substrate for catalysing ATP generation, and an inhibitor for
ROS generation, makes it a unique molecule to preserve
mitochondrial function under pathophysiological conditions.

measure of net superoxide production in the matrix. Under
physiological conditions, the production of ROS and their
consumption in the form of H2O2 is finely tuned. ROS are
mainly produced as superoxide by complexes I and III in the
mitochondrial electron transport chain [34]. Superoxide is
dismutated to H2O2 by manganese superoxide dismutase
(MnSOD) in the mitochondrial matrix and copper/zinc
superoxide dismutase (Cu/ZnSOD) in the mitochondrial
intermembrane space and cytosol. The resulting H2O2 can
easily diffuse across membranes to be detected by the assay.
However, H2O2 can also be consumed by matrix enzymes, e.g.
glutathione peroxidases, and cause an underestimate of
superoxide production by competing with the efflux of H2O2
[35]. By a series of redox reactions, H2O2 is converted to H2O,
while glutathione (GSH) is oxidized to glutathione disulfide
(GSSG). GSSG is reduced back to GSH by the oxidation of
pyridine nucleotides (NADH/NADPH). The GSH/GSSG ratio
provides an estimate of cellular redox buffering capacity, thus
playing a key role in maintaining redox homeostasis [36].
ADP can regulate mitochondrial ROS production through
complexes I and III, as well as general redox state of the
mitochondrial matrix (NADH/NADPH, GSH) via oxidative
phosphorylation. Indeed, the addition of ADP caused a
decrease in H2O2 export from control mitochondria (Figure 4A
and C). However, in t-BH treated mitochondria the fine tuning
of ROS production and consumption by ADP in mitochondria is
disturbed (Figure 4B-D). t-BH treatment induces the oxidation
of pyridine nucleotides [37] and GSH [38]. GSSG is not
exported from the mitochondria [39] and increased GSSG
formation may decrease the activity of mitochondrial redoxsensitive proteins [40–46]. As a result, H2O2 export is increased
in t-BH mitochondria (Figure 4B-D). Although ADP does reduce
ROS, it is not able to bring it down to control level (Figure 4D).
Thus, the t-BH results demonstrate that ADP regulates
mitochondrial CRC not only via ROS reduction, but via some
other mechanisms as well.

Conclusion
ADP is well known to desensitize the mPTP to
intramitochondrial Ca2+, so that the mitochondria can take up
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Figure 5. ADP is a master regulator of mitochondrial ATP production, Ca2+ homeostasis, and ROS generation. Under
physiological conditions, optimal ADP concentrations in mitochondrial matrix serve effectively to maximize ATP generation while
minimizing ROS. ROS production via ETC and annihilation via matrix scavenger systems (gluthatione/thioredoxin) is finely
balanced. Under pathological conditions, mitochondrial Ca2+ and ROS increase, stimulate excessive mPTP opening and thus the
signaling pathway for injury. These detrimental effects are countered by a concomitant increase in ADP, which allows the
mitochondria to endure a larger load of Ca2+ and ROS, maintaining mitochondrial integrity and function when it is most critical.
ANTm – ANT in the “m”-conformation; ANTc – ANT in the “c”-conformation; CL - cardiolipin; CypD – cyclophilin D; ETC – electron
transport chain; GR – glutathione reductase; GRx – glutathione peroxidase; GSH – reduced glutathione; GSSG – oxidized
glutathione; MCCs – mitochondrial calcium channels; MnSOD – manganese superoxide dismutase; mPTP – mitochondrial
permeability transition pore; Prx3 – peroxiredoxin 3; ROS – reactive oxygen species, TCA – tricarboxylic acid cycle; Trx2red reduced thioredoxin 2; Trx2ox – oxidized thioredoxin 2; TrxR2 – thioredoxin reductase 2.
doi: 10.1371/journal.pone.0083214.g005
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